Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Molecular Templates Inc (MTEM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 208,293
  • Shares Outstanding, K 36,736
  • Annual Sales, $ 3,400 K
  • Annual Income, $ -23,140 K
  • 60-Month Beta 3.10
  • Price/Sales 16.34
  • Price/Cash Flow N/A
  • Price/Book 1.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.16
  • Number of Estimates 2
  • High Estimate 0.51
  • Low Estimate -0.20
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +161.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.67 +23.13%
on 03/05/19
5.84 -1.54%
on 03/11/19
+0.63 (+12.30%)
since 02/21/19
3-Month
3.19 +80.25%
on 12/24/18
5.84 -1.54%
on 03/11/19
+2.40 (+71.64%)
since 12/21/18
52-Week
3.19 +80.25%
on 12/24/18
9.98 -42.38%
on 03/26/18
-3.33 (-36.67%)
since 03/21/18

Most Recent Stories

More News
Molecular Templates to Present a Corporate Overview at the Cowen & Company 39th Annual and the Oppenheimer & Co. 29th Annual Health Care Conferences

Molecular Templates, Inc. (Nasdaq: MTEM), a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies...

MTEM : 5.74 (+1.23%)
New Data on Molecular Templates' Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2019

Molecular Templates, Inc., (Nasdaq: MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies...

MTEM : 5.74 (+1.23%)
Molecular Templates Appoints Roger J. Waltzman, M.D., as Chief Medical Officer

Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company's proprietary engineered toxin bodies (ETBs), which are differentiated,...

MTEM : 5.74 (+1.23%)
New Research Coverage Highlights Overstock, Regeneron Pharmaceuticals, Molecular Templates, The Ensign Group, Limoneira, and Primo Water -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Overstock.com, Inc. (NASDAQ:OSTK),...

LMNR : 23.36 (+0.21%)
PRMW : 15.29 (+1.19%)
MTEM : 5.74 (+1.23%)
REGN : 398.86 (-1.64%)
ENSG : 50.93 (+2.11%)
OSTK : 19.59 (-0.20%)
Molecular Templates to Present at the Evercore ISI and BMO Healthcare Conferences

Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company's proprietary engineered toxin bodies (ETBs), which are differentiated,...

MTEM : 5.74 (+1.23%)
Molecular Templates, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular" or "Molecular Templates"), a clinical-stage oncology company focused on the discovery and development of the company's proprietary engineered toxin...

MTEM : 5.74 (+1.23%)
Molecular Templates to Present at the UBS Global Healthcare Conference

Molecular Templates, Inc. (Nasdaq:MTEM) ("Molecular"), a clinical-stage oncology company focused on the discovery and development of the company's proprietary engineered toxin bodies (ETBs), which are...

MTEM : 5.74 (+1.23%)
Consolidated Research: 2018 Summary Expectations for RadNet, Molecular Templates, Federated Investors, Kadant, Heartland Financial, and Calyxt -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of RadNet, Inc. (NASDAQ:RDNT),...

KAI : 89.44 (+1.01%)
FII : 29.34 (+0.41%)
HTLF : 44.65 (+0.18%)
CLXT : 18.56 (-2.16%)
MTEM : 5.74 (+1.23%)
RDNT : 13.73 (-1.15%)
Molecular Templates, Inc. Reports Fourth Quarter 2017 Financial Results

Update on MT-3724 Provided at World ADC Conference; More Data Expected in 2Q18

MTEM : 5.74 (+1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MTEM with:

Business Summary

Molecular Templates Inc. is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies for the treatment of cancers and other serious diseases. Molecular Templates Inc., formerly known as Threshold Pharmaceuticals Inc., is headquartered...

See More

Key Turning Points

2nd Resistance Point 6.06
1st Resistance Point 5.86
Last Price 5.74
1st Support Level 5.39
2nd Support Level 5.11

See More

52-Week High 9.98
Fibonacci 61.8% 7.39
Fibonacci 50% 6.59
Fibonacci 38.2% 5.78
Last Price 5.74
52-Week Low 3.19

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar